Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS)-sensitive cellular components refer to a broad array of biological molecules—including proteins, lipids, and nucleic acids—that undergo structural or functional modifications in response to fluctuations in local ROS levels. These components act as critical nodes in redox signaling, where specific cysteine residues in proteins (such as those in the Keap1/Nrf2 or NF-kB pathways) serve as molecular switches that sense oxidative stress and trigger protective or pathological cellular responses (Sies et al., 2017, Nature Reviews Molecular Cell Biology). In a therapeutic context, these components are often exploited for the development of ROS-responsive drug delivery systems, where high levels of ROS in diseased tissues (like tumors or inflamed sites) trigger the release of therapeutic agents from sensitive nanocarriers (Trachootham et al., 2009, Nature Reviews Drug Discovery). While essential for normal physiological signaling, the dysregulation of ROS-sensitive components is a hallmark of various pathologies, including cancer, neurodegeneration, and cardiovascular diseases. Consequently, targeting the redox state of these components or utilizing their sensitivity for site-specific drug activation represents a significant area of pharmacological research (Murphy et al., 2011, Nature Reviews Drug Discovery).
Redox modulation, ROS scavenging, ROS-triggered drug release, Cysteine oxidation/reduction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species-sensitive cellular components (ROS-sensitive components).